The abstract is read at the publisher; the summary is JClub's.
Genetic variants in redox-related pathways are linked to NSAID hypersensitivity in Spanish Europeans, with GSTM5 rs11101989 and SOD1 variants showing phenotype-specific susceptibility and reduced enzyme activity.
- Why it matters: Individual genetic determinants of cross-reactive versus single-NSAID hypersensitivity are unclear, limiting biomarker-based risk assessment and safer NSAID prescribing.
- What they did: In a multicentre prospective case-control study, Spanish individuals of European ancestry were genotyped for SNVs in redox- and immune-related genes using discovery and independent replication, then serum GST, SOD, and AKR activities were measured by genotype.
- The result: GSTM5 rs11101989 CC carriers had reduced total serum GST activity and increased CR-NSAID susceptibility, while SOD1 rs2070424 and rs2833483 increased SNIUAA susceptibility with reduced serum SOD activity; AKR1C3 and IL4R variants showed opposite susceptibility directions, supporting redox-pathway biomarkers pending validation in independent populations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.